Држава: Велика Британија
Језик: Енглески
Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)
Primidone
SERB
N03AA03
Primidone
250mg
Oral tablet
Oral
No Controlled Drug Status
Caution - AMP level prescribing advised
BNF: 04080100; GTIN: 5060311320001
PACKAGE LEAFLET: INFORMATION FOR THE USER MYSOLINE ® 250MG TABLETS (primidone) This medicine is available as the above name but will be referred to as Mysoline throughout the following leaflet. Please note that the leaflet also contains information about the other strength (Mysoline ® 50mg Tablets). READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Mysoline is and what it is used for 2. What you need to know before you take Mysoline 3. How to take Mysoline 4. Possible side effects 5. How to store Mysoline 6. Contents of the pack and other information 1. WHAT MYSOLINE IS AND WHAT IT IS USED FOR Mysoline contains primidone as the active ingredient; this belongs to a group of medicines used to treat seizures. Mysoline is used for the treatment of certain types of epilepsy, seizures (fits) or shaking attacks (essential tremor). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MYSOLINE DO NOT TAKE MYSOLINE: • If you are allergic to primidone, phenobarbital, or to any of the other ingredients of this medicine (these are listed in Section 6: Further information). • If you have porphyria (a rare inherited disorder of metabolism) or anyone in your family has it. WARNINGS AND PRECAUTIONS This medication is not effective in certain forms of epilepsy. Your doctor will assess the need to prescribe you this medicine depending on the form of epilepsy you are suffering from. Consult your doctor immediately if the frequency of your seizures increases or if seizures of a different type appear. Talk to your Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mysoline 250mg Tablets Primidone SERB 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Primidone Ph. Eur. 250 mg 3 PHARMACEUTICAL FORM White uncoated oral tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 'Primidone' is indicated in the management of grand mal and psychomotor (temporal lobe) epilepsy. It is also of value in the management of focal or Jacksonian seizures, myoclonic jerks and akinetic attacks. Management of essential tremor. _4.2 _ _POSOLOGY AND METHOD OF ADMINISTRATION _ Posology Primidone should be started at the lowest possible dose in the evening and thereafter the dose should be increase in a stepwise manner to minimise adverse reactions. Epilepsy Treatment must always be planned on an individual basis. In many patients primidone treatment may be given as monotherapy, but in some, Primidone will need to be combined with other anticonvulsants or with supporting therapy. In certain patients, it may be advisable to give a larger dose when the seizures are more frequent. For instance: 1) If the attacks are nocturnal then all or most of the daily dose may be given in the evening; 2) If the attacks are associated with some particular event such as menstruation, a slight increase in the appropriate dose is often beneficial. • In adults: Initial dose: it is usually 125 mg in a single intake in the evening. Then every 3 days, the daily dose is increased in a stepwise approach by 125 mg until the patient is receiving 500 mg daily. Thereafter, every 3 days, the daily dose (given in 2 divided doses) is increased by 250 mg, until control is obtained or until the maximum tolerated dose and may be up to 1.5 g daily. Maintenance dose: Milligrams Adults 750 - 1500 • In children: Initial dose: it is usually 125 mg in a single intake in the evening. Then every 3 days, the daily dose is increased in a stepwise approach by 125 mg until the patient is receiving 500 mg daily. Thereafter, every 3 days, the daily dose (given in 2 Прочитајте комплетан документ